Targeting first trimester trophoblast cell metabolism modulates its susceptibility to Zika virus infection
Journal of Cellular Physiology · 2023
DOI: 10.1002/jcp.30970 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular Physiology, 2023. Verfasst von Diego Kafer und 8 weiteren Autor:innen. Beteiligte Einrichtung: Laboratorio de Inmunofarmacología, Instituto de Química Biológica de la Facultad de Ciencias Exactas y Naturales (IQUIBICEN), Universidad de Buenos A…. Hauptthemen laut MEDLINE: Trophoblasts, Zika Virus, Zika Virus Infection. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 27 Literaturangaben.
Abstract (Originalsprache)
In the last 15 years Zika virus (ZIKV) caused several outbreaks of increasing scale in Micronesia, South Pacific islands, and more recently in the Caribbean and South America. The severity of the clinical presentation in neonates from pregnant women infected with ZIKV during the last outbreak supports the relevance of unraveling the mechanism of infection and viral persistence in the placenta with local viral isolates. Here, we investigated the relevance of trophoblast metabolic rewiring for viral multiplication and the role of the vasoactive intestinal peptide (VIP) as an endogenous factor associated with placental restriction to ZIKV infection at early pregnancy. Our in vitro model demonstrated that ZIKV triggers metabolic rewiring in first trimester cytotrophoblast‐derived cells by increasing glucose utilization as fuel to sustain its replication, decreasing long‐chain polyunsaturated fatty acid uptake, and promoting lipid droplets accumulation to favor its multiplication. Of note, variations in nutrient availability modulated viral spread in trophoblast cultures. The presence of VIP during trophoblast infection impaired ZIKV infective particle production and viral replication, restoring cell migration and metabolism. Moreover, the blockade of endogenous VIP signaling increased viral particle production and the viral entry receptor AXL expression. These results highlight the potential role of VIP as an endogenous antiviral factor related to trophoblast cell permissiveness to ZIKV infection at early pregnancy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Laboratorio de Inmunofarmacología, Instituto de Química Biológica de la Facultad de Ciencias Exactas y Naturales (IQUIBICEN), Universidad de Buenos Aires-CONICET, Buenos Aires, Argentina.
- Laboratorio de Estrategias Antivirales, Instituto de Química Biológica de la Facultad de Ciencias Exactas y Naturales (IQUIBICEN), Universidad de Buenos Aires-CONICET, Buenos Aires, Argentina.
ORCID-Profile: Diego Kafer, Cybele Garcia, Daiana Vota
Zitieren
APA
Kafer, D., Marquez, A., Merech, F., Hauk, V., Paparini, D., Ramhorst, R., Leirós, C. P., Garcia, C., & Vota, D. (2023). Targeting first trimester trophoblast cell metabolism modulates its susceptibility to Zika virus infection. Journal of Cellular Physiology. https://doi.org/10.1002/jcp.30970
Vancouver
Kafer D, Marquez A, Merech F, Hauk V, Paparini D, Ramhorst R, et al. Targeting first trimester trophoblast cell metabolism modulates its susceptibility to Zika virus infection. Journal of Cellular Physiology. 2023. doi:10.1002/jcp.30970
BibTeX
@article{Kafer2023,
author = {Kafer, Diego and Marquez, Agostina and Merech, Fátima and Hauk, Vanesa and Paparini, Daniel and Ramhorst, Rosanna and Leirós, Claudia Pérez and Garcia, Cybele and Vota, Daiana},
title = {Targeting first trimester trophoblast cell metabolism modulates its susceptibility to Zika virus infection},
journal = {Journal of Cellular Physiology},
year = {2023},
doi = {10.1002/jcp.30970}
}
EUVIMED